WEST LAFAYETTE, Ind., Aug. 28, 2024 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in non-clinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., Inotiv’s President and CEO, and Beth Taylor, Chief Financial Officer, will attend the 8th Annual Lake Street Best Ideas Growth Conference Thursday, September 12, 2024 in New York City.
Management is scheduled to host one-on-one meetings with investors and attendees during the conference. Investors interested in arranging one-on-one meetings should contact their Lake Street conference representative.
About Inotiv
Inotiv, Inc. is a leading contract research organization dedicated to providing non-clinical and analytical drug discovery and development services and research models and related products and services. The company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical development phases, all while increasing efficiency, improving data and reducing the cost of bringing new drugs to market. Inotiv is committed to supporting discovery and development goals and helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world. Additional information about Inotiv can be found here: https://www.inotiv.com/.
This release may contain forward-looking statements that are subject to risks and uncertainties, including, but not limited to, risks and uncertainties related to the impact of recent events related to non-human primate relationships on the Company’s business, operations, results, financial condition, cash flows and assets, the company’s ability to service its outstanding indebtedness and comply with the covenants under its credit agreement, compliance with the resolution and plea agreements with the DOJ and the expected impacts on the company in connection with the compliance plan, the compliance monitor and the expected financial obligations; changes in the market and demand for the company’s products and services, development, marketing and sale of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful completion, integration and business and financial consequences thereof, government regulations, inspections and investigations, claims and litigation against or involving the Company, its business and/or its industry, the impact of closings and consolidations, expansion and related efforts and various other market and operating risks, including those described in The company’s filings with the US Securities and Exchange Commission.